IMARC Group, a leading market research company, has recently releases report titled “Poultry Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global poultry vaccines market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How big is the poultry vaccines market?

The global poultry vaccines market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.3% during 2023-2028.

What is the poultry vaccines?

Poultry disease refers to an infectious animal disease affecting various poultry species, including chicken, turkey, duck, goose, etc. It causes diarrhea, facial edema, twisting of the neck, paralysis of wings and legs, cyanosis of comb, reduced egg production, sudden death, etc. Consequently, poultry animals undergo vaccination to boost their immunity and produce antibodies, which can inactivate pathogens.

Poultry vaccines also aid in preserving the health of these animals by functioning as a preventive measure against the outbreak of contagious diseases. Presently, they can be administered via injections, feed, eye-drop, drinking water, etc.

Market Trends:

The escalating prevalence of zoonotic diseases, such as avian influenza and bird flu, is one of the primary factors driving the poultry vaccines market. Furthermore, the increasing demand for animal disease diagnostics and treatments is also catalyzing the market growth. Besides this, the growing consumption of animal-derived products and the rising concerns towards food safety are further augmenting the global market.

Moreover, several leading market players are investing in research and development (R&D) activities for introducing advanced poultry vaccines to help in protecting animals against infectious bursal diseases, infectious bronchitis, virulent Newcastle disease (VND), etc., which is also bolstering the market growth. In addition to this, the introduction of non-replicating recombinant antigens and live-gene detected vaccines is expected to stimulate the poultry vaccines market over the forecasted period.

Request to get the sample report:

Competitive Landscape With Key Players:

The competitive landscape of the global poultry vaccines market has been studied in the report with the detailed profiles of the key players operating in the market.

Poultry Vaccines Key Companies:

  • AniCon Labor GmbH (SAN Group)
  • Biovac Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Elanco
  • Hester Biosciences Limited
  • Merck & Co. Inc.
  • Phibro Animal Health Corporation
  • Venkys India
  • Zoetis Inc.

Key Market Segmentation:

The report has segmented the market into the following categories:

Breakup by Disease:

  • Infectious Bronchitis
  • Avian Influenza
  • Newcastle Disease
  • Marek’s Disease
  • Others

Breakup by Product:

  • Recombinant Vaccine
  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Subunit Vaccine
  • Others

Breakup by Dosage Form:

  • Liquid Vaccine
  • Freeze Dried Vaccine

Breakup by Application:

  • Breeder
  • Broiler
  • Layer

Breakup by End User:

  • Veterinary Hospitals
  • Poultry Firm
  • Poultry Vaccination Center

Breakup by Region:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Speak to Analyst:

Key highlights of the report:             

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Industry Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Browse More Reports:

About Us                                                                      

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Tags: , , ,

See Campaign:

Contact Information:

Contact US IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA USA: +1-631-791-1145 | Asia: +91-120-433-0800 Email: [email protected] Follow us on Twitter: @imarcglobal LinkedIn:

PR-Wirein, Reportedtimes, iCN Internal Distribution, Research Newswire, English